Johnson Midwest Financial’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-14
Closed -$1K 299
2021
Q3
$1K Buy
+14
New +$1.18K ﹤0.01% 286

Other funds holding ARKG

Johnson Midwest Financial's ARKG Position: Q4 2021 in Review

Johnson Midwest Financial sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2021, closing a stake of 14 shares — an estimated $1K sold.

Johnson Midwest Financial first reported a position in ARKG in Q3 2021 and held it in 1 quarter. The position peaked at $1K in Q3 2021. 460 funds tracked by Wall St. Rank hold ARKG as of Q4 2021.

  • Johnson Midwest Financial reported no remaining ARK Genomic Revolution ETF position as of Q4 2021 after selling out during the quarter.
  • Johnson Midwest Financial sold 14 ARK Genomic Revolution ETF shares in Q4 2021, an estimated $1K.
  • Johnson Midwest Financial first reported a position in ARK Genomic Revolution ETF in Q3 2021 and held it in 1 quarter.
  • Johnson Midwest Financial's ARK Genomic Revolution ETF position peaked at $1K in Q3 2021.
  • 460 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2021.

Based on Johnson Midwest Financial's 13F filing for Q4 2021, filed 26 Jan 2022.